Consider validity, clinical relevance, and applicability of albumin for critically ill patients

doi:10.1136/bmj.317.7154.343

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Martin Offringa, Consultant neonatologist

Emma Children's Hospital, Academic Medical Centre, 1105 AZ Amsterdam, Netherlands

EDITOR—Because of a series of questions I have received about the current clinical use of human albumin in critically ill patients, I wish to clarify the message that I intended my editorial last week to convey.1

Given the current evidence as summarised by the Cochrane albumin reviewers group,).2 the …